autologous breast cancer cells engineered to secrete GM-CSF
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for autologous breast cancer cells engineered to secrete GM-CSF, covering 2021-10-14 to 2021-10-14. Get the full timeline:
Most recent: Clinical Trial Update: Vaccination With Autologous Breast Cancer Cells Engineered to Secrete Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Metastatic Breast Cancer Patients [Phase 1]